Stanislav Glezer
Chief Tech/Sci/R&D Officer at INOGEN, INC.
Net worth: 129 975 $ as of 2024-03-30
Stanislav Glezer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INOGEN, INC. | Chief Tech/Sci/R&D Officer | 2021-06-20 | - |
| Diabetes Foundation of New Jersey | Director/Board Member | 2019-07-23 | - |
Career history of Stanislav Glezer
Former positions of Stanislav Glezer
| Companies | Position | Start | End |
|---|---|---|---|
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | 2018-08-31 | 2021-05-31 |
| ADOCIA | Chief Tech/Sci/R&D Officer | 2017-07-25 | 2018-04-30 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Chief Tech/Sci/R&D Officer | 2016-02-29 | 2017-02-28 |
| Sanofi SA | Corporate Officer/Principal | - | - |
Training of Stanislav Glezer
| California Coast University | Masters Business Admin |
| Yevdokimov MSUMD | Doctorate Degree |
Statistics
International
| United States | 6 |
| France | 3 |
| Russia | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| INOGEN, INC. | Health Technology |
| ADOCIA | Health Technology |
| Private companies | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Sanofi SA | Health Technology |
| Diabetes Foundation of New Jersey |
- Stock Market
- Insiders
- Stanislav Glezer
- Experience
